These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 28183621

  • 1. A transferrin variant as the targeting ligand for polymeric nanoparticles incorporated in 3-D PLGA porous scaffolds.
    Lopes AM, Chen KY, Kamei DT.
    Mater Sci Eng C Mater Biol Appl; 2017 Apr 01; 73():373-380. PubMed ID: 28183621
    [Abstract] [Full Text] [Related]

  • 2. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X, Li J, Yan M.
    Drug Dev Ind Pharm; 2016 Oct 01; 42(10):1590-9. PubMed ID: 26942448
    [Abstract] [Full Text] [Related]

  • 3. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z, Huang H, Huang L, Du L, Sun Y, Duan Y.
    Int J Mol Sci; 2017 Apr 13; 18(4):. PubMed ID: 28406431
    [Abstract] [Full Text] [Related]

  • 4. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC, Lin PI, Wang CC.
    Nanomedicine (Lond); 2011 Aug 13; 6(6):1011-26. PubMed ID: 21707298
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R, Wang Y, Li X, Bao W, Xia G, Chen W, Cheng J, Xu Y, Guo L, Chen B.
    Drug Des Devel Ther; 2015 Aug 13; 9():2705-19. PubMed ID: 26045659
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.
    Nanomedicine; 2007 Dec 13; 3(4):246-57. PubMed ID: 18068091
    [Abstract] [Full Text] [Related]

  • 9. Influence of Parathyroid Hormone-Loaded PLGA Nanoparticles in Porous Scaffolds for Bone Regeneration.
    Gentile P, Nandagiri VK, Pabari R, Daly J, Tonda-Turo C, Ciardelli G, Ramtoola Z.
    Int J Mol Sci; 2015 Aug 28; 16(9):20492-510. PubMed ID: 26343649
    [Abstract] [Full Text] [Related]

  • 10. [Effects of modification of transferrin on cytotoxicity and intracellular delivery of paclitaxel loaded PLGA nanoparticles].
    Jin SH, Li NC, Zhang ZH, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2012 Nov 27; 92(44):3151-4. PubMed ID: 23328431
    [Abstract] [Full Text] [Related]

  • 11. Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior.
    Nandagiri VK, Gentile P, Chiono V, Tonda-Turo C, Matsiko A, Ramtoola Z, Montevecchi FM, Ciardelli G.
    J Mech Behav Biomed Mater; 2011 Oct 27; 4(7):1318-27. PubMed ID: 21783141
    [Abstract] [Full Text] [Related]

  • 12. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
    Zhu B, Zhang H, Yu L.
    Biomed Pharmacother; 2017 Feb 27; 86():547-554. PubMed ID: 28024291
    [Abstract] [Full Text] [Related]

  • 13. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V, Denora N, Lopalco A, Lopedota A, Cutrignelli A, Lasorsa FM, Agostino G, Franco M.
    Mol Pharm; 2014 Mar 03; 11(3):859-71. PubMed ID: 24410438
    [Abstract] [Full Text] [Related]

  • 14. Biodegradable poly(D,L-lactide-co-glycolide)/poly(L-γ-glutamic acid) nanoparticles conjugated to folic acid for targeted delivery of doxorubicin.
    Jaimes-Aguirre L, Morales-Avila E, Ocampo-García BE, Medina LA, López-Téllez G, Gibbens-Bandala BV, Izquierdo-Sánchez V.
    Mater Sci Eng C Mater Biol Appl; 2017 Jul 01; 76():743-751. PubMed ID: 28482586
    [Abstract] [Full Text] [Related]

  • 15. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
    Cui Y, Xu Q, Chow PK, Wang D, Wang CH.
    Biomaterials; 2013 Nov 01; 34(33):8511-20. PubMed ID: 23932498
    [Abstract] [Full Text] [Related]

  • 16. PLGA/polymeric liposome for targeted drug and gene co-delivery.
    Wang H, Zhao P, Su W, Wang S, Liao Z, Niu R, Chang J.
    Biomaterials; 2010 Nov 01; 31(33):8741-8. PubMed ID: 20727587
    [Abstract] [Full Text] [Related]

  • 17. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU, Kona S, Wadajkar AS, Desai F, Vadla A, Nguyen KT.
    J Biomed Mater Res A; 2012 Aug 01; 100(8):1998-2005. PubMed ID: 22566409
    [Abstract] [Full Text] [Related]

  • 18. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H, Zhao Y, Wu Y, Hu YL, Nan K, Nie G, Chen H.
    Biomaterials; 2011 Nov 01; 32(32):8281-90. PubMed ID: 21807411
    [Abstract] [Full Text] [Related]

  • 19. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N, Rahmani R, Paknejad M.
    Life Sci; 2020 Nov 15; 261():118361. PubMed ID: 32861796
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J, Abnous K, Tafaghodi M, Mokhtarzadeh A, Ramezani M.
    Eur J Pharm Biopharm; 2017 Apr 15; 113():60-74. PubMed ID: 28012991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.